Product Information

ZOLMITRIPTAN 5 MG NASAL SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $49.3568 per EA under NDC 45802071191. Its NADAC has been published 254 times since Jan 12, 2022.

FDA first approved this application on Sep 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the zolmitriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ZOLMITRIPTAN 5 MG NASAL SPRAY

zolmitriptan
$49.3568per EA
High Outlier

Strength

5 mg/1

NDC

45802071191

Classification

Generic

Dosage Form

SPRAY

Route

NASAL

Effective Date

11/18/2026

Active Ingredients

ZOLMITRIPTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA212469

FDA Approved

9/30/2021

TE Code

AB

On Market Since

11/16/2021

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has been published 254 times since Jan 12, 2022, and over the history we have for it it has declined 36.1%. The table below summarizes its recorded NADAC range and movement.

Current price$49.3568 per EA
All-time high$80.8103 (Nov 16, 2022)
All-time low$38.6728 (Nov 19, 2025)
52-week high$49.3568
52-week low$38.6728
Median price$59.1756
Average price$60.2462
Largest weekly change-33.7% (Apr 17, 2024)
Weeks tracked254
Tracking sinceJan 12, 2022

Price History

1W

+2.8%

1M

+12.1%

3M

+19.5%

6M

+12.3%

1Y

+27.6%

3Y

-33.4%

5Y

N/A

All

-36.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zolmitriptan market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZOLMITRIPTAN 5 MG NASAL SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG NASAL SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $49.3568 per EA (NDC 45802071191), effective Nov 18, 2026.

How has the price of ZOLMITRIPTAN 5 MG NASAL SPRAY changed over time?

Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has declined 36.1%. It has been tracked across 254 weekly CMS publications since Jan 12, 2022.

What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG NASAL SPRAY?

Since Jan 12, 2022, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has ranged from a low of $38.6728 (Nov 19, 2025) to a high of $80.8103 (Nov 16, 2022), with a median of $59.1756 per EA.

Are there cheaper alternatives to ZOLMITRIPTAN 5 MG NASAL SPRAY?

No other NADAC-published product currently shares the active ingredient and strength of ZOLMITRIPTAN 5 MG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ZOLMITRIPTAN 5 MG NASAL SPRAY?

ZOLMITRIPTAN 5 MG NASAL SPRAY (NDC 45802071191) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.